Sarah Missel joined Immatics in 2011, where she started as Scientist in Immunology and subsequently held several positions leading cross-functional teams in various internal and collaboration projects. Besides her tasks in Translational Development, she was responsible for R&D strategy and communications. Her current work as Development Lead, is focused on development and oversight of Immatics’ TCER® pipeline and portfolio, including the translation of preclinical projects into early phase clinical trials.
Sarah studied Pharmacy at the University of Würzburg and gathered some experience in clinical research at GSK. Her academic research at the Institute of Virology of TU/Helmholtz Centre Munich was focused on therapeutic HIV vaccines and immune monitoring in clinical trials.
Sarah Missel holds a State Exam in Pharmacy and a PhD in Pharmacology/Immunology/Virology from LMU and Helmholtz Centre Munich.